REMIKAF is contraindicated: For epidural or intrathecal administration due to the presence of glycine in the formulation [see Nonclinical Toxicology under Precautions].
In patients with hypersensitivity to remifentanil (e.g., anaphylaxis) [see ADVERSE REACTIONS].